Medical care of older persons in residential aged care facilities


The Silver Book
Medication management
☰ Table of contents


Residents' medication needs are complex. They are large users of medications due to the high prevalence of disease and comorbidity, and they are dependant on RACF staff for administering their medication.

Optimal medication management in RACFs involves a multidisciplinary and systematic approach with residents or their representative, GPs, pharmacists, aged care nurses, other RACF staff and health service providers. The APAC Guidelines for medication management in residential aged care facilities recommended that each facility has a Medication Advisory Committee with GPs, pharmacists (supplying pharmacists and if different, the pharmacist conducting medication reviews), RACF management and staff (including nurses), and resident advocate/s working together to facilitate the quality use of medicines.67 Figure 2 summarises the organisational issues for medication management in RACFs that are addressed in the guidelines.

Particular aspects for GPs to consider include (also refer to the APAC guidelines mentioned above):

  • an efficient and effective partnership between residents, prescribing GPs, dispensing and review pharmacists and administering RACF staff
  • monitoring of risks of adverse medication reactions and interactions, particularly if polypharmacy is combined with over-the-counter medications, or alternative supplements
  • regular reviews of prescribed medication following changes in comorbidity and progression of disease
  • prescribing as required (PRN) and nurse initiated medication (NIM) to cover anticipated events
  • use of alternative oral formulations
  • requirements for end of life care.

 


Prescribing medication


All people have the right to give informed consent or to refuse any medical intervention including medication. It is therefore important to discuss treatment issues with residents and their relatives/carers or representatives using easily understood language. Treatment objectives from the perspective of residents may be affected by their experience of the ageing process, cognitive impairment, physical disability, chronic disease, pain, accumulated losses and social isolation.68

General principles of prescribing medication for older people include69:

  • nonmedication treatments should be used wherever possible
  • treat adequately to achieve goals of therapy
  • new medications: start low, go slow and increase slowly checking for tolerability and response
  • use the lowest effective maintenance dose
  • generally prescribe from a limited range of medications and ensure familiarity with their effects in older people
  • prescribe the least number of medications, with the simplest dose regimens
  • consider the person's functional and cognitive ability when prescribing
  • consider medication adverse effects if there is a decline in physical or cognitive functions or self care abilities
  • prescribe suitable formulations of medications if a person experiences swallowing problems
  • provide patient education, using Consumer Medicine Information (CMI) or simple verbal and written instructions for each medication to reinforce adherence
  • regularly review treatment and the person's ability to manage the medications
  • consider the medicines already being taken including prescription, nonprescription and complementary medicines.

Prescribing medications include routine medications, as well as pre-planning medications when required (PRN) for anticipated events from specific conditions (eg. allergic reaction, angina, asthma, behaviours of concern, constipation, diabetes, diarrhoea, pain).

Decisions to prescribe medication are optimally70:

  • evidence based
  • made in the context of the patient's medical and psychosocial condition, prognosis, quality of life and wishes
  • made in the context that overuse, underuse, and inappropriate use of medications are equally important quality of care concerns
  • made with disclosure of confidential information, only as necessary for direct patient care.

General practitioners have access to several excellent sources of evidence based information on prescribing medication. The National Prescribing Service website includes the Therapeutic Advice and Information Service (TAIS) for health care professionals. TAIS provides immediate access to independent medication and therapeutics information for the cost of a local call (1300 138 677). Therapeutic guidelines for management of patients with common clinical conditions are available as pocket sized books, CDROMs for installation on personal computers, and versions for use on health department intranets, commercial prescribing software, and hand held computers. These are obtainable from here  or telephone 1800 061 260. The Australian medicines handbook (AMH) provides a comparative, practical formulary covering most of the medications marketed in Australia. It is available in annual book editions, CDROM, PDA, or online (via the Health Communications Network . Also provided by the AMH is the Medication choice companion: aged care, which is particularly relevant for older people living in RACFs.71

In addition, best practice for medication management in older adults includes these steps72:

  • Identify the presence and nature of the resident's symptom, disease, condition, impairment, or risk
  • Assess the resident to identify the cause of the problem, or document why an assessment was not performed
  • Gather and assess information about the resident's current medications and treatments as well as responses and adverse reactions to previous medications and treatments
  • Identify and document the reason(s) why the disease, condition, symptom, or impairment needs to be treated, or why treatment is not to be provided
  • Choose an appropriate medication or modify an existing medication regimen
  • Identify and document the objective(s) of treatment
  • Consider and document the benefits and risks of treatment
  • Consider and document possible medication interactions
  • Order the selected agent
  • Order appropriate precautions in administering the medication, including instructions for resident monitoring
  • Assess and document the resident's status during or at the end of treatment
  • Assess the resident for possible adverse medication reactions
  • Modify the medication regimen as indicated by its effectiveness or by the presence of complications.

Medication orders are written on RACF medication charts by qualified prescribers taking into account the needs and views of residents (or representatives), policies of the RACF, legislative requirements and professional standards. The qualified prescriber is usually the resident's GP, but may also be a locum or hospital doctor, geriatrician or palliative care physician. In some situations, registered dental practitioners or registered nurse practitioners are able to prescribe medications.

It is considered best practice for GPs to work closely with RACF staff to regularly review and rewrite medication charts to maintain a continuum of medication for residents. The APAC National guidelines to achieve the continuum of quality use of medicines between hospital and community should be referred to when a resident moves between different health care settings (eg. hospital to RACF).73 A residential medication management review, conducted by the GP and pharmacist, is recommended for each resident on admission and regularly thereafter (see Organisational aspects).

 


Dispensing, storage and disposal of medication


Pharmacists work closely with GPs to dispense medication as prescribed and conduct medication reviews. They work closely with RACF staff to supply the dispensed medications in a suitable form and ensure their safe handling at the facility. The Pharmaceutical Society of Australia has developed standards for pharmacy services to residents74:

  • Maintain appropriate systems for the supply of medicines to the facility
  • Ensure that medicines are delivered to the RACF in a timely manner
  • Ensure that medicines are stored within the RACF in accordance with legislative and manufacturers' storage requirements
  • Monitor stock medicines used in the RACF
  • Check medications brought into the RACF by new patients, as soon as practicable after admission, to ensure consistency with currently prescribed medications
  • Conduct a comprehensive medication review of all residents at regular intervals and maintain appropriate records
  • In consultation with medical practitioners identify residents who may require therapeutic medication monitoring
  • Identify, monitor and document adverse medication events
  • Provide information on medicines that adequately meet the needs of the RACF
  • Provide an education program appropriate to the needs of the RACF
  • RACFs must have a mechanism in place for the disposal of returned, expired and unwanted medicines.

 


Administering medication


Medications can be administered by a registered nurse who is qualified to administer medication, or self administered by the resident (who is assessed as competent to do so). Dose administration aids (DAAs) are used to provide medications where there is not a registered nurse qualified to administer medications, or to assist residents who are self administering medications. 'Blister' packaging systems or 'compartmentalised boxes' are packed and labelled by a pharmacist and the medications administered directly from the DAA to the resident. If the prescriber alters any medication order, the entire DAA must be returned to the supplying pharmacist for repackaging. Residential aged care facility staff should refer to relevant state/territory legislation for further information on DAAs.

It is recommended that RACFs have policies and procedures for the alteration of oral dose formulations (eg. crushing tablets or opening capsules) to make it easier to administer medication to residents with swallowing difficulties. In some cases, the practice of altering the form of medication may result in reduced effectiveness, a greater risk of toxicity, or unacceptable presentation to residents in terms of taste or texture. Controlled release medications should not be crushed or altered without consultation with the pharmacist. Residential aged care facility staff could refer to Appendix F of the APAC Guidelines for medication management in residential aged care facilities for more information on alteration of oral formulations (Figure 2).

 

Medication advisory committee (MAC) (Recommendation 1)*

Example of terms of reference and meeting agenda (Appendix A and B)*

Example of a medication management administration policy (Appendix C)*

Provision of pharmacy services to an RACF (Appendix D)*

 

Residential Aged Care Facility (RACF)

Medication chart (Recommendation 2)*

All residents including respite care

Electronic or manual and photo ID

Include self administered and complementary medicines

Medication review (Recommendation 3)*

Reviews should be recorded on resident's record and medication chart

Regular review/use multidisciplinary team

Consult with patient

Standing orders (Recommendation 5)*

Emergency supplies

Consult relevant state/territory legislation

Nurse initiated medication (Recommendation 6)*

Defined drug list and protocols

GP access to list

Regular review

Consult state/territory legislation and guidelines

Self administered medications (Recommendation 7)*

RACF policy and process re assessment of patient competency. Example of assessment of a resident's ability to self administer (Appendix E)*

Regular review within care plan

Document agreement/copy to patient

Alteration of oral formulations (Recommendation 8)*

Alteration of solid dosage - methods

Documentation on medication chart

Medicines list remain unaltered and regular update

OH&S considerations

Example of guidelines and standard operating procedures for altering medication dose forms (Appendix F)*

Dose administration Aids (DAA) (Recommendation 9)*

Use to encourage compliance with medication

Roles and responsibilities of pharmacist

Policy for the administration of medications offsite

DAA indicate if ceased/withheld

Emergency supplies (Recommendation 14)*

Refer to state/territory legislation

MAC policy use/documentation/stock control

Minimal range of medicines in after hours use

Other

Administration of medications (Recommendation 4)*

Information resources (Recommendation 10)*

Storage and disposal of medicines (Recommendation 11 and 12)*

Complementary/self selected medicines (Recommendation 13)*

  1. Flicker L. Clinical issues in aged care, managing the interface between acute, sub-acute, community and residential care. Aust Health Rev 2002;25:136-9.
  2. Lewis G, Pegram R. Residential aged care and general practice. Workforce demographic trends 1984-2001. Med J Aust 2002;177:84-6.
  3. Gray L, Woodward M, Scholes R, Fonda D, Busby W. Geriatric medicine: a pocket book for doctors, nurses, other health professionals and students. 2nd ed. Melbourne: Ausmed Publications, 2000.
  4. Aged Care Association Australia (ANHECA). Aged care Australia: the future challenges. Canberra: ANHECA, 2004.
  5. Aged Care Standards Agency (ACSA). Accreditation guide for residential aged care services. Canberra: ACSA Ltd., 2001.
  6. Australian Institute of Health and Welfare (AIHW). Residential aged care services in Australia 2000-1. A statistical overview. Canberra: AIHW, 2002.
  7. Carers Australia. Submission to the House of Representatives Standing Committee on Ageing: inquiry into long term strategies to address the ageing of the Australian population, 2004.  [Accessed 19 April 2005].
  8. Johnson N, Iddon P, Pierce G. Outside looking in: a resource kit on carer friendly practices in aged care facilities. Carers Victoria, 2003.
  9. Flicker L, op. cit.
  10. National Aged Care Alliance (NACA). NACA issues paper. The aged care - health care interface, 2003. [Accessed 19 April 2005].
  11. Saliba D, Solomon D, Rubenstein L, Young R, Schnelle J, Roth C, Wegner N. Quality indicators for the management of medical conditions in nursing home residents. J Am Med Dir Assoc 2004;5:297-309.
  12. Australian Nursing and Midwifery Council (ANMC). ANMC national competency standards for the enrolled nurse. [Accessed 01 August 2005].
  13. Healy J, Richardson S. Who cares for the elders? What we can and can't know from existing data. Adelaide: National Institute of Labour Studies, Flinders University, 2003.
  14. Australian Pharmaceutical Advisory Council (APAC). Guidelines for medication management in residential aged care facilities. 3rd ed. Canberra: APAC, Commonwealth of Australia, 2002.
  15. Health Professional Council of Australia. Membership and member organisations, 2005.  [Accessed 23 May 2005].
  16. Whitehead C, Penhall R. Australian Society for Geriatric Medicine. Position statement no. 8. Geriatric Assessment and Community Practice, 2000.  [Accessed 19 April 2005].
  17. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  18. Care Australia. A guide to palliative care service development: a population based approach, 2005.  [Accessed 19 April 2005].
  19. Ruth D, Wong R, Haesler E. General Practice in residential aged care, partnerships for 'round the clock' medical care. Melbourne: North West Melbourne Division of General Practice, 2004.  [Accessed 22 April 2005].
  20. Ibid.
  21. The Royal Australian College of General Practitioners (RACGP). Standards for general practices. 2nd ed. Melbourne: RACGP, 2000.
  22. RACGP and Committee of Presidents of Medical Colleges. Handbook for the management of health information in private medical practice, 2002. [Accessed 19 April 2005].
  23. Dorevitch M, Davis S, Andrews G. Guide for assessing older people in hospitals. Prepared for the Care of Older Australians Working Group and Department of Health and aged Care, May 2005 (in press).
  24. Gray LC, Newbury JW. Health assessment of elderly patients. Aust Fam Physician 2004;33:795-7.
  25. Siggins Miller Consultants and School of Population Health, University of Queensland. Executive summary. In: A report to the Brisbane North Division of General Practice (BNDGP). The residential care project. Queensland: BNDGP, 2002. [Accessed 26 April 2005]
  26. Dorevitch M, Davis S, Andrews G, op. cit.
  27. National Health Medical Research Council (NHMRC). Communicating with patients: advice for medical practitioners. Canberra: Commonwealth of Australia, NHMRC, 2004.
  28. Reuban DB, Herr KA, Pacala JT, et al. Geriatrics at your fingertips: 2005, 7th ed. New York: The American Geriatrics Society, 2005. [Accessed 17 June 2005].
  29. Ibid.
  30. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  31. Dorevitch M, Davis S, Andrews G, op. cit.
  32. Ibid.
  33. World Health Organisation (WHO). International classification of functioning, disability and health. Geneva: WHO, 2001.
  34. Mahoney FI, Bethel D. Functional evaluation: the Bethel Index. Maryland State Med Journal 1965;14:56-61.
  35. Dorevitch M, Davis S, Andrews G, op. cit.
  36. Pierce G, Nankervis J. Putting carers in the picture: Improving the focus on carer needs in aged care assessment. Melbourne: Carers Association Victoria, 1998.
  37. Doka DJ. Grief, loss and care giving. In: Doka KJ, Davidson JD, editors. Caregiving and loss. Washington, DC: Hospice Foundation of America, 2001;215-30.
  38. Boss P. Ambiguous loss: learning to live with unresolved grief. London: Harvard University Press, 2000.
  39. Darzins P, Molloy DW, Strang D, editors. Who can decide? The six step capacity assessment process. Adelaide: Memory Australia Press, 2000.
  40. Ibid.
  41. Ibid.
  42. Reuban DB, Herr KA, Pacala JT, et al, op. cit.
  43. Maas ML, Reed D, Myonghwa P, et al. Outcomes of family involvement in care intervention for caregivers of individuals with dementia nursing research. Nurs Res 2004;53:76-86.
  44. O'Shea M. An unrecognised grief: loss and grief issues for carers - a workers guide. Melbourne: Carers Association Victoria, 2001.
  45. Payda C, Draper B, Luscombe G, Erlich F, Maharja J. Stress in carers of the elderly - a controlled study of patients attending a Sydney medical practice. Aust Fam Physician 1999;28:233-7.
  46. Steinberg MA, Cartwright CM, Najman JM, MacDonald SM, Williams GM. Healthy ageing, health dying: community and health professional perspectives on end of life decision making: report to the Research and Development Grant Advisory Committee (RADGAC) of the Department of Human Services and Health. University of Queensland Department of Social and Preventive Medicine, February 1996.
  47. Cartwright CM, Parker MH. Advance care planning and end of life decision making. Aust Fam Physician 2004;33:815-9.
  48. Australian Medical Association (AMA) Committee on Care of Older People. Making decisions for later life: the medical profession's role. Working paper. AMA 2002.
  49. Ruth D, Wong R, Haesler E. General Practice in residential aged care: clinical information sheet: Advance care planning to improve end of life care, in Residential Aged Care Kit. Melbourne: North West Melbourne Division of General Practice, 2004. [Accessed 19 April 2005].
  50. Cartwright CM, Parker MH, op. cit.
  51. 51. World Health Organisation (WHO). National cancer control programmes: policies and managerial guidelines, 2nd ed. Geneva: WHO, 2002.
  52. Australian Government Department of Health and Ageing. Guidelines for a palliative approach in residential aged care. Canberra: Rural Health and Palliative Care Branch, Australian Government Department of Health and Ageing, 2004.  [Accessed 10 May 2005].
  53. WHO. National cancer control programmes: policies and managerial guidelines, op. cit.
  54. Rousseau P. Spirituality and the dying patient. J Clin Oncol 2003;21(9 Suppl):54-6.
  55. Murray SA, Kendall M, Boyd K, Sheikh, A. Illness trajectories and palliative care. BMJ 2005;330:1007-11.
  56. Australian Government Department of Health and Ageing 2004. Guidelines for a Palliative Approach in Residential Aged Care, op. cit.
  57. Taylor A, Box M. Palliative Care Australia: multicultural palliative care guidelines, 1999. Accessed 31 May 2005].
  58. Writing Group for Therapeutic Guidelines: Palliative Care. Therapeutic Guidelines: Palliative Care, version 1. Melbourne: Therapeutic Guidelines Ltd, 2001.
  59. Jones J, Willis D. In search of a good death: what is a good death? BMJ 2003;327:224.
  60. Age Health and Care Study Group. The future of health and care of older people: the best is yet to come. London: Age Concern, 1999.
  61. Ellershaw J, Wilkinson S, editors. Care of the dying - a pathway to excellence. New York: Oxford University Press, 2003.
  62. Ibid.
  63. Liverpool Care Pathway, 2005. [Accessed 10 May 2005].
  64. The RACGP. Clinical audit: what is a clinical audit? 2002. [Accessed 10 May 2005].
  65. ACSA, op. cit.
  66. Liverpool Care Pathway project. Beacon resource pack September 2002 - August 2003. [Accessed 10 May 2005].
  67. Australian Pharmaceutical Advisory Council (APAC), op. cit.
  68. Australian Medicines Handbook. Australian Medicines Handbook: medication choice companion: aged care. Adelaide: Australian Medicine Handbook, 2003.
  69. Ibid.
  70. Wagerty D, Brickley R. American Medical Directors Association and American Society of Consultant Pharmacists joint position statement on the Beers List of Potentially Inappropriate Medications in Older Adults, 2005.  [Accessed 26 April 2005].
  71. Australian Medicines Handbook, op. cit.
  72. Swagerty D, Brickley R, op. cit.
  73. APAC. APAC national guidelines to achieve the continuum of quality use of medicines between hospital and community. Canberra: APAC, Commonwealth of Australia, 1998.
  74. Pharmaceutical Society of Australia (PSA). Professional practice standards. Pharmacy services to residential care facilities, in Australia Pharmaceutical Formulary and Handbook. 19th ed. Canberra: PSA, 2004.
  75. Brown TM, Boyle MF. Clinical review ABC of psychological medicine: delirium. BMJ 2002;325:644-7.
  76. Writing Group for Therapeutic Guidelines: Psychotropic. Therapeutic Guidelines: Psychotropic, version 5. Melbourne: Therapeutic Guidelines Limited, 2003.
  77. Ibid.
  78. Australian Medicines Handbook, op. cit.
  79. Innouye SK, Charpentier PA. Precipitating factors for delirium in hospitalised elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852-7.
  80. Ibid.
  81. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  82. Ibid.
  83. Australian Medicines Handbook, op. cit.
  84. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op cit.
  85. Brodaty H, Draper BM, Low LF. Behavioural and psychological symptoms of dementia: a seven tiered model of service delivery. Med J Aust 2003;178:231-4. [Accessed 29 April 2005].
  86. Alzheimer's Australia and Access Economics. Dementia estimates and projections: Australian states and territories. Report by Access Economics for Alzheimer's Australia, 2005.  [Accessed 29 April 2005].
  87. Scherer S. Getting ACROSS Dementia: A dementia management resource for general practice. Melbourne: Southcity GP Services and Alzheimer's Association Victoria, 2003.
  88. Bridges-Webb C, Wolk J. Care of patients with dementia in general practice guidelines. Sydney: The Royal Australian College of General Practitioners and NSW Health, 2003.  [Accessed 29 April 2005].
  89. Ibid.
  90. Pond D, Brodaty H. Diagnosis and management of dementia in general practice. Aust Fam Physician 2004;33:789-93.
  91. Folstein MF, Folstein S, McHugh PR. Mini-Mental State a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
  92. Hodkinson HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972;1:233-8.
  93. Dorevitch M, Davis S, Andrews G, op. cit.
  94. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit
  95. Australian Medicines Handbook, op. cit.
  96. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T. A depression management program for older patients and their general practitioners. Melbourne: SPHERE: A national mental health project, 1995. 
  97. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  98. Juby A, Tench S, Baker V. The value of clock drawing in identifying executive cognitive dysfunction in people with a normal Mini-Mental State Examination score. CMAJ 2002;167:859-64.
  99. Bridges-Webb C, Wolk J, op. cit.
  100. Ibid.
  101. Scherer S, op. cit.
  102. Bridges-Webb C, Wolk J, op. cit.
  103. Kane RL, Ouslander JG, Abrass IB. Essentials of clinical geriatrics. 4th ed. New York: McGraw-Hill, 1999.
  104. Maas ML, Reed D, Myonghwa P, et al, op. cit.
  105. Rosen J, Mittal V, Mulsant BH, Degenholsz H, Castle N, Fox D. Educating the families of nursing home residents: a pilot study using a computer-based system. J Am Med Dir Assoc 2003;4:128-34.
  106. Scherer S, op. cit.
  107. Van Doorn C, Gruber-Baldini AL, Zimmerman S, et al. Dementia as a risk factor for falls and fall injuries among nursing home residents. J Am Geriatr Soc 2003;51:1213-8.
  108. Ouslander JG, Simmons S, Schnelle J, Uman G, Fingold S. Effects of prompted voiding on fecal continence among nursing home residents. J Am Geriatr Soc 1996;44:424-8.
  109. Ostaszkiewicz J, Johnston L, Roe B. Timed voiding for the management of urinary incontinence in adults (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester: Wiley.
  110. Scherer S, op. cit.
  111. Brodaty H, Draper BM, Low LF, op. cit.
  112. National Dementia Behaviour Advisory Service (Alzheimer's Australia). ReBOC: reducing behaviours of concern: a hands on guide. Canberra: Australian Government Department of Health and Ageing, 2003.
  113. Popplewell P, Phillips P. Is it dementia? Which one? Aust Fam Physician 2002;31:319-21.
  114. National Prescribing Service. Galantamine (Reminyl) prolonged release capsules for dementia in Alzheimer's disease. NPS RADAR Review, December 2004. [Accessed 16 May 2005].
  115. Neal M, Briggs M. Validation therapy for dementia (Cochrane Review). In: The Cochrane Library, Issue 3, 2003. Chichester: Wiley.
  116. Australian Government Department of Health and Ageing. Decision making tool: responding to issues of restraint in aged care. Canberra: Australian Government Department of Health and Ageing, 2004.  [Accessed 10 May 2005].
  117. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  118. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  119. National Prescribing Service. Galantamine (Reminyl) prolonged release capsules for dementia in Alzheimer's disease, op. cit.
  120. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  121. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  122. Australian Medicines Handbook, op. cit, 5-8.
  123. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  124. Ibid.
  125. Brodaty H, Draper BM, Low LF, op. cit.
  126. Australian Medicines Handbook, op. cit, 5-8.
  127. Scherer S, op. cit.
  128. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  129. Australian Medicines Handbook, op. cit, p.5-8.
  130. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  131. National Prescribing Service. Resperidone (Risperdal) for behavioural disturbances in dementia. NPS RADAR Review, April 2005.   [Accessed 16 May 2005].
  132. Ibid.
  133. Australian Medicines Handbook, op. cit, 5-8.
  134. Ibid.
  135. Katona CLE, Livingstone G. Functional psychiatric illness in old age. In: Tallis RC, Fillit HM, editors. Brocklehurst''s Textbook of Geriatric Medicine and Gerontology, 6th ed. London: Churchill Livingstone, 2002.
  136. Teresi J, Holmes D, Ramirez M, Eimicke J. Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry, Psychiatr Epidemiol 2001;36:613-20.
  137. Fleming R, editor. Challenge depression: a manual to help staff identify and reduce depression in aged care facilities. Sydney: The Hammond Care Group, 2001.
  138. Fleming R, op. cit.
  139. Snowdon J. Late-life depression: what can be done? Aust Prescr 2001;24:65-7.
  140. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington DC: American Psychiatric Association Press, 1994.
  141. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  142. Fleming R, op. cit.
  143. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  144. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  145. Khan F. Poststroke depression. Aust Fam Physician 2004;33:831-4.
  146. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  147. Khan F, op. cit.
  148. Fleming R, op. cit.
  149. Khan F, op. cit.
  150. Australian Medicines Handbook, op. cit.
  151. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  152. Snowdon J, op. cit.
  153. Scott E, Pesiah C, Hickie I, Ricci C, Davenport T, op. cit.
  154. Khan F, op. cit.
  155. Bird MJ, Parslow RA. Potential for community programs to prevent depression in older people. Med J Aust 2002;177:S107-110.
  156. Snowdon J, op. cit.
  157. Writing Group for Therapeutic Guidelines: Psychotropic, op. cit.
  158. Ibid.
  159. Australian Medicines Handbook, op. cit.
  160. Chan D, Phoon S, Yeoh E. Australian Society for Geriatric Medicine. Position statement no. 12. Dysphagia and aspiration in older people. Australas J Ageing 2004;23:198-202.  [Accessed 19 April 2005].
  161. Martino R, Pron G, Diamant N. Screening for oropharyngeal dysphagia in stroke: insufficient evidence for guidelines. Dysphagia 2000;15:19-30.
  162. Australian Medicines Handbook, op. cit.
  163. Chan D, Phoon S, Yeoh E, op. cit.
  164. Australian Medicines Handbook, op. cit.
  165. Jonsen AR, Siegler M, Winslade WJ. Clinical ethics: a practical approach to ethical decisions in clinical medicine, 5th ed. New York: McGraw-Hill, 2002.
  166. Scherer S, Jennings C, Smeaton M, Thompson P, Stein M. A multi-disciplinary practice guideline for hip fracture prevention. Australas J Ageing 2002 21:203-10.
  167. Australian Council for Safety and Quality in Health Care. Preventing falls and harm from falls. Best practice guidelines for Australian hospitals and residential aged care facilities. Canberra, ACT: Australian Government Department of Health and Ageing, 2005; in press.
  168. Ibid.
  169. Ibid.
  170. Ibid.
  171. Guideline for the prevention of falls in older persons. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention. J Am Geriatr Soc 2001;49:664-72.
  172. Australian Council for Safety and Quality in Health Care, op. cit.
  173. Writing Group for Therapeutic Guidelines: Therapeutic Guidelines: endocrinology, version 4. Melbourne: Therapeutic Guidelines Limited, 2004.
  174. Australian Council for Safety and Quality in Health Care, op. cit.
  175. Fonda D. Improving management of urinary incontinence in geriatric centres and nursing homes. Victorian Geriatric Peer Review Group. Aust Clin Rev 1990;10:66-71.
  176. Gardner J. Promoting continence in nursing homes: a national project. Urol Nurs 1992;12(2):83.
  177. Reuban DB, Herr KA, Pacala JT, et al, op. cit.
  178. The RACGP (West Australian Research Unit). Managing incontinence in general practice. Clinical practice guidelines. Perth: RACGP, 2002.  [Accessed 6 June 2005].
  179. Australian Medicines Handbook, op. cit.
  180. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  181. Ibid.
  182. Australian Medicines Handbook, op. cit.
  183. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  184. Australian Medicines Handbook, op. cit.
  185. Ibid.
  186. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  187. Sapsford R. Physiotherapy for pelvic floor dysfunction in the aged care setting. In: Nitz JC, Hourigan SR, editors. Physiotherapy practice in residential aged care. Edinburgh: Butterworth Heinemann, 2004.
  188. The RACGP (West Australian Research Unit), op. cit.
  189. Kalantar JS, Howell S, Tally MJ. Prevalence of faecal incontinence and associated risk factors: an underdiagnosed problem in the Australian community? Med J Aust 2002;176:54-7.
  190. Reuban DB, Herr KA, Pacala JT, et al, op. cit.
  191. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  192. Australian Medicines Handbook, op. cit.
  193. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  194. Reuban DB, Herr KA, Pacala JT, et al, op. cit.
  195. Ibid.
  196. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  197. Kamm MA. Faecal incontinence: common and treatable Med J Aust 2002;176:47-8.
  198. The RACGP (West Australian Research Unit), op. cit.
  199. Australian Government Department of Health and Ageing. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting, 2004.  [Accessed 19 April 2005].
  200. Ibid.
  201. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  202. Australian Government Department of Health and Ageing. Infection control guidelines for the prevention of transmission of infectious diseases in the health care setting, op. cit.
  203. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  204. Australian Medicines Handbook, op. cit.
  205. National Health and Medical Research Council. The Australian immunisation handbook. 8th ed. Canberra: Commonwealth of Australia, 2003.
  206. Ruth D, Wong R, Haesler E. General practice in residential aged care: clinical information sheet: Urinary tract infections. In: Residential Aged Care Kit. Melbourne: North West Melbourne Division of General Practice, 2004. [Accessed 19 April 2005]
  207. Ibid.
  208. Australian Government Department of Health and Ageing. Guidelines for a palliative approach in residential aged care, op. cit.
  209. Ruth D, Wong R, Haesler E, op. cit.
  210. Mater Hospital (Oncology and Palliative Care Wards). Authorised opioid conversion chart. Brisbane: Mater Hospital, 2005.
  211. Writing Group for Therapeutic Guidelines: Analgesic: Therapeutic Guidelines: Analgesic, version 4. Melbourne: Therapeutic Guidelines Limited, 2002.
  212. Ibid.
  213. Joanna Briggs Institute. Pressure sores - part 1: prevention of pressure related damage. Best Practice 1997;1:1-6.  [Accessed 6 June 2005].
  214. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  215. Stacey MC. Preventing pressure ulcers [editorial]. Med J Aust 2004;180:316.
  216. Prentice JL, Stacey MC. Pressure ulcers: the case for improving prevention and management in Australian health care settings. Primary Intention 2001;9:111-20.
  217. Australian Wound Management Association. Clinical practice guidelines for prediction and prevention of pressure ulcers. Perth: Cambridge Media, 2001.
  218. Queensland Health. Pressure ulcer prevention and management resource guidelines. Brisbane: Queensland Health, 2004.  [Accessed 6 June 2005].
  219. Ibid.
  220. Stacey MC, op. cit.
  221. Norton D, Exton-Smith AN, McLaren R. An investigation of geriatric nursing problems in hospitals. London: Churchill Livingstone. National Corporation for Care of Old People, 1975.
  222. Bergstrom N. A clinical trial of the Braden Scale for predicting pressure score risk. Nurs Clin North Am 1987;22:417-28.
  223. Waterlow J. Pressure sores: a risk assessment card. Nurs Times 1985;81:49-55.
  224. Joanna Briggs Institute. Pressure sores - part 1: prevention of pressure related damage. Best Practice 1997;1:1-6. [Accessed 6 June 2005].
  225. Dorevitch M, Davis S, Andrews G, op. cit.
  226. Norton D, Exton-Smith AN, McLaren R, op. cit.
  227. Queensland Health, op. cit
  228. Australian Wound Management Association, op. cit.
  229. Gray L, Woodward M, Scholes R, Fonda D, Busby W, op. cit.
  230. Ibid.
  231. Reuban DB, Herr KA, Pacala JT, et al, op. cit.
  232. Queensland Health, op. cit.
  233. Ibid.
  234. Ibid.
  235. Guy RJ, Di Natale R, Kelly HA, et al. Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy. Med J Aust 2004;180:640-2.
  236. Australian Medicines Handbook, op. cit.
  237. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  238. Guy RJ et al., op. cit.
  239. Australian Medicines Handbook, op. cit.
  240. Ibid.
  241. National Health and Medical Research Council, op. cit.
  242. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  243. Ibid.
  244. Australian Medicines Handbook, op. cit.
  245. Ruth D, Wong R, Haesler E. General practice in residential aged care: clinical information sheet: Urinary Tract Infections, op. cit.
  246. Australian Medicines Handbook, op. cit, 5-8.
  247. Ruth D, Wong R, Haesler E. General practice in residential aged care: clinical information sheet: Urinary tract infections, op. cit.
  248. Ibid.
  249. Australian Medicines Handbook, op. cit, 5-8.
  250. Ruth D, Wong R, Haesler E. General practice in residential aged care: clinical information sheet: Urinary tract infections, op. cit.
  251. Australian Medicines Handbook, op. cit, 5-8.
  252. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  253. Australian Medicines Handbook, op. cit, 5-8.
  254. Ruth D, Wong R, Haesler E. General practice in residential aged care: clinical information sheet: Urinary tract infections, op. cit.
  255. Ibid.
  256. Writing Group for Therapeutic Guidelines: Antibiotic, op. cit.
  257. Australian Medicines Handbook, op. cit, 5-8.
  258. Ruth D, Wong R, Haesler E. General Practice in residential aged care, partnerships for 'round the clock' medical care, op. cit.
  259. Australian Government Department of Health and Ageing. Medicare Benefits Schedule, 2005. Available atwww7.health.gov.au/pubs/mbs/index.htm [Accessed 10 May 2005].
  260. Aged Care Standards Agency. Continuous improvement for residential aged care: an education package, 2001.  [Accessed 10 May 2005].
  261. NSW Health Department. Easy guide to clinical practice improvement. A guide for health care professionals, 2002. [Accessed 10 May 2005].
  262. Dorevitch M, Davis S, Andrews G, op. cit.
  263. Flicker l, Loguidice D, Carlin JB, Ames D. The predictive value of dementia screening in clinical populations. Int J Geriatric Psychiatry 1997;12:203-9.
  264. Dorevitch M, Davis S, Andrews G, op. cit.